Rectitude Holdings, Ltd. (NASDAQ:RECT – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 9,200 shares, a growth of 19.5% from the October 15th total of 7,700 shares. Based on an average daily volume of 9,800 shares, the short-interest ratio is presently 0.9 days. Approximately 0.4% of the company’s shares are short sold.
Hedge Funds Weigh In On Rectitude
A hedge fund recently bought a new stake in Rectitude stock. Frank Rimerman Advisors LLC purchased a new position in Rectitude Holdings, Ltd. (NASDAQ:RECT – Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 14,000 shares of the company’s stock, valued at approximately $46,000. Frank Rimerman Advisors LLC owned approximately 0.10% of Rectitude at the end of the most recent reporting period.
Rectitude Stock Performance
NASDAQ:RECT traded down $0.06 during trading hours on Friday, hitting $3.44. The company had a trading volume of 8,414 shares, compared to its average volume of 8,024. The company has a quick ratio of 1.37, a current ratio of 1.86 and a debt-to-equity ratio of 0.24. The company’s 50-day simple moving average is $3.28. Rectitude has a 52 week low of $2.70 and a 52 week high of $4.25.
About Rectitude
Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, gloves, safety footwear, personal fall arrest systems, portable fire extinguishers and traffic products. The Company also offers auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.
See Also
- Five stocks we like better than Rectitude
- The 3 Best Fintech Stocks to Buy Now
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What Are Trending Stocks? Trending Stocks Explained
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Pros And Cons Of Monthly Dividend Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Rectitude Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rectitude and related companies with MarketBeat.com's FREE daily email newsletter.